Clinical Trials Directory

Trials / Completed

CompletedNCT01388699

Migraine and Endothelial Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Recently, there is evidence that endothelial activation and dysfunction are associated with migraine, especially in female migraineurs with aura. Our objectives were to determine whether novel endothelial function markers are altered in female migraineurs with aura compared to age-matched controls.

Detailed description

Our objectives were to determine whether novel endothelial function methods and novel markers of endothelial activation are associated with migraine in female migraineurs with aura. Migraine is an independent risk factor for stroke, especially in young women with aura symptoms. Endothelial dysfunction is a risk factor for cardiovascular diseases. Recent studies suggest that there is a link between migraine with aura and endothelial activation, dysfunction and impaired vascular reactivity. In this case-control study the investigators examine several novel biomarkers of endothelial function such as endothelial progenitor cells and endothelial microparticles as well as novel methods such as reactive hyperemic peripheral arterial tonometry in female migraineurs with aura and age-matched controls.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2011-08-01
Completion
2011-12-01
First posted
2011-07-07
Last updated
2018-07-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01388699. Inclusion in this directory is not an endorsement.